Neoadjuvant Endocrine Therapy in Breast Cancer
NCT03397537
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Highly Endocrine Responsive Operable Breast Cancer
Interventions
DRUG:
Letrozole 2.5Mg Tablet
DRUG:
GnRH analogue
Sponsor
Guangdong Provincial People's Hospital